Current and historical daily PE Ratio for SER (
Serina Therapeutics Inc
) from 2024 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Serina Therapeutics stock (SER) PE ratio as of Jun 05 2024 is 32.47.
More Details
Serina Therapeutics Inc (SER) PE Ratio (TTM) Chart
Serina Therapeutics Inc (SER) PE Ratio (TTM) Historical Data
View and export this data going back to 2024. Start your Free Trial
Total 49
- 1
| Serina Therapeutics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-05 | At Loss | 2024-05-01 | At Loss |
| 2024-06-04 | At Loss | 2024-04-30 | At Loss |
| 2024-06-03 | At Loss | 2024-04-29 | At Loss |
| 2024-05-31 | At Loss | 2024-04-26 | At Loss |
| 2024-05-30 | At Loss | 2024-04-25 | At Loss |
| 2024-05-29 | At Loss | 2024-04-24 | At Loss |
| 2024-05-28 | At Loss | 2024-04-23 | At Loss |
| 2024-05-24 | At Loss | 2024-04-22 | At Loss |
| 2024-05-23 | At Loss | 2024-04-19 | At Loss |
| 2024-05-22 | At Loss | 2024-04-18 | At Loss |
| 2024-05-21 | At Loss | 2024-04-17 | At Loss |
| 2024-05-20 | At Loss | 2024-04-16 | At Loss |
| 2024-05-17 | At Loss | 2024-04-15 | At Loss |
| 2024-05-16 | At Loss | 2024-04-12 | At Loss |
| 2024-05-15 | At Loss | 2024-04-11 | At Loss |
| 2024-05-14 | At Loss | 2024-04-10 | At Loss |
| 2024-05-13 | At Loss | 2024-04-09 | At Loss |
| 2024-05-10 | At Loss | 2024-04-08 | At Loss |
| 2024-05-09 | At Loss | 2024-04-05 | At Loss |
| 2024-05-08 | At Loss | 2024-04-04 | At Loss |
| 2024-05-07 | At Loss | 2024-04-03 | At Loss |
| 2024-05-06 | At Loss | 2024-04-02 | At Loss |
| 2024-05-03 | At Loss | 2024-04-01 | At Loss |
| 2024-05-02 | At Loss | 2024-03-28 | At Loss |
Serina Therapeutics Inc (SER) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Serina Therapeutics Inc
NAICS : 541714
SIC : 2834
ISIN : US81751A1088
Description
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers